$BAH

Jefferies lowers Booz Allen Hamilton stock price target on civil revenue headwinds

Jefferies cut Booz Allen Hamilton's (BAH) price target to $75 from $80, citing civil revenue declines. Analyst Sheila Kahyaoglu noted a 22% sales drop in fiscal 2026, hurting growth. BAH trades at $67.64, down 33% YoY, with a 3.5% dividend yield. Q1 fiscal 2027 EPS beat estimates at $1.81, while revenue matched at $2.8B. UBS raised its target to $78, citing a 15% YoY increase in funded backlog.

Original reporting
Published Oct 7, 2026, 2:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 2:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$BAH
Neutral
high confidence
Mentioned
$BAH
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BAHNeutralMed
01

Why it matters

Analyst target changes and contract news provide fresh valuation inputs that could move the stock.

02

Market read

New analyst guidance and a sizable contract award create immediate trading considerations for BAH.

03

What to watch

The new $85 million Department of War contract could offset civil segment weakness.

Relevance 7/10Novelty 7/10Timing: today

Background

The article summarizes recent analyst actions and a new government contract for Booz Allen Hamilton.

Company-level read

Ticker impact

$BAHNeutralHigh confidence
Context

Jefferies lowered its price target to $75 and reinstated coverage, while UBS raised its target to $78, providing new analyst guidance for Booz Allen Hamilton.

Expected impact

potential downside as the market prices in Jefferies' lower target, tempered by UBS's higher target

Evidence & confidence

Price target changes are fresh primary disclosures that can shift valuation expectations in the short term.

Market effects

Defense and consulting sector may see re‑rating as analysts adjust expectations for civil segment performance.

U.S. defense contractors could experience modest volatility following the target revisions.

Limited to U.S. equities; no broader macro impact.

Counterpoint

Investors might view the UBS upgrade as a catalyst for a short‑term rally despite Jefferies' downgrade.

Key entities

  • Jefferies

    Lowered price target to $75 and reinstated coverage.

  • UBS

    Raised price target to $78.

  • U.S. Department of War

    Awarded an $85 million contract to Booz Allen Hamilton.

Related articles

$BAHMed

Why Booz Allen Hamilton (BAH) Stock Is Up Today

Booz Allen Hamilton (BAH) shares rose 2.7% after the U.S. Navy awarded it a potential $827.9M contract for business management support services. The company's stock closed at $70.47, up 1.5% from the previous day. BAH's shares have shown volatility, with a 17% decrease since the year's start and a 32.3% drop from its 52-week high.

$BAHLow

Navy Awards 7 Spots on $828M Business Management Contract

The U.S. Navy awarded seven companies, including CACI International and Booz Allen Hamilton, spots on an $828M contract for business management support services. The contract has a base value of $276M and could run through 2035. Contractors will compete for task orders to assist with budgeting, analysis, and program management.

$BAHMedAI 8/10

Can BAH's $39 Billion Backlog Offset Its Q1 Revenue Decline?

Booz Allen Hamilton (BAH) reported a 4.2% revenue decline to $2.8B in Q1 2027, but adjusted EBITDA rose 7.4% to $334M, and EPS increased 22.3% to $1.81. The company's backlog grew 3% to $39B, with a book-to-bill ratio of 1.5. BAH's profitability and cash flow improved despite the revenue drop, according to the company.